| 专论编号 | 物质名称 | 证书持有人 | 持有人ORG-ID和LOC-ID | 证书编号 | 发布日期 | 证书状态 | 到期续期 | 证书结束日期 | 证书类型 | 上一程序的结束日期 | 历史数据 程序类型|结论|日期 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3094 | Erlotinib hydrochloride, Form-A | HETERO LABS LIMITED Hyderabad IN | 100011681;100018664 | CEP 2024-455 - Rev 00 | 2025/11/24 | Valid | 24/11/2030 | Chemical | 2025/11/24 | New application|CEP granted|24/11/2025 | |
| 3094 | Erlotinib hydrochloride, Crystalline form-A, micronised and non-micronised | MSN LABORATORIES PRIVATE LIMITED Kardanur Village IN | 100011732;100023530 | CEP 2025-362 - Rev 00 | 2025/11/24 | Valid | 24/11/2030 | Chemical | 2025/11/24 | New application|CEP granted|24/11/2025 | |
| 1783 | Glycopyrronium bromide | SHANDONG RISEN-SUN PHARMACEUTICAL CO., LTD. Taian CN | 100050469;100088103 | CEP 2024-413 - Rev 00 | 2025/11/24 | Valid | 24/11/2030 | Chemical | 2025/11/24 | New application|CEP granted|24/11/2025 | |
| 1180 | Buprenorphine, Process II | SPECGX LLC Webster Groves US | 100017269;100031662 | CEP 2025-111 - Rev 00 | 2025/11/24 | Valid | 24/11/2030 | Chemical | 2025/11/24 | New application|CEP granted|24/11/2025 | |
| 1210 | Fentanyl | MACFARLAN SMITH LIMITED Edinburgh GB | 100008070;100010773 | CEP 2007-158 - Rev 02 | 2025/11/21 | Valid | Chemical | 2025/11/21 | Minor revision|CEP granted|21/11/2025 | ||
| 2191 | Atorvastatin calcium, Trihydrate Form-I, Micronised and Non-micronised | MSN PHARMACHEM PRIVATE LIMITED Sangareddy District IN | 100014794;100023345 | CEP 2011-068 - Rev 04 | 2025/11/21 | Valid | Chemical | 2025/11/21 | Minor revision|CEP granted|21/11/2025; Minor revision|CEP granted|05/01/2024; Minor revision|CEP granted|10/02/2023; Monograph revision|Accepted - CEP remains valid|18/05/2022; Minor revision|Accepted - CEP remains valid|18/01/2021 |
||
| 888 | Ciprofloxacin Hydrochloride | SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai IN | 100008538;100018201 | CEP 1998-090 - Rev 14 | 2025/11/21 | Valid | Chemical | 2025/11/21 | Minor revision|CEP granted|21/11/2025; Minor revision|CEP granted|15/10/2024; Minor revision|CEP granted|29/08/2024; Minor revision|CEP granted|18/08/2022; Minor revision|CEP granted|17/02/2022; Minor revision|CEP granted|29/09/2020 |
||
| 136 | Apomorphine hydrochloride hemihydrate | FRANCOPIA Paris FR | 100041331;100098338 | CEP 2008-332 - Rev 05 | 2025/11/21 | Valid | Chemical | 2025/11/21 | Minor revision|CEP granted|21/11/2025; Notification|CEP granted|01/03/2024; Notification|CEP granted|02/05/2022 |
||
| 14 | Calcium carbonate, Sieved grade I (35) | OMYA SAS Omey FR | 100020502;100081592 | CEP 2001-366 - Rev 05 | 2025/11/21 | Valid | Chemical | 2025/11/21 | Minor revision|CEP granted|21/11/2025; Minor revision|CEP granted|25/05/2021; Minor revision|CEP granted|08/12/2020 |
||
| 619 | Levomenthol | FREY + LAU GMBH Henstedt-Ulzburg DE | 100017333;100026131 | CEP 2019-058 - Rev 01 | 2025/11/21 | Valid | Chemical | 2025/11/21 | Renewal|CEP granted|21/11/2025; Renewal|Abandoned|04/07/2025; Notification|Accepted - CEP remains valid|13/08/2021; Notification|Accepted - CEP remains valid|25/02/2021 |
||
| 2930 | Valganciclovir hydrochloride | SHANGHAI PHARMA GROUP CHANGZHOU KONY PHARMACEUTICAL CO., LTD. Luoyang Town CN | 100020594;100034407 | CEP 2024-326 - Rev 00 | 2025/11/21 | Valid | 21/11/2030 | Chemical | 2025/11/21 | New application|CEP granted|21/11/2025 | |
| 260 | Amoxicillin trihydrate, Sterile | NORTH CHINA PHARMACEUTICAL GROUP SEMISYNTECH CO. LTD. Shijiazhuang CN | 100023274;100032418 | CEP 2024-583 - Rev 00 | 2025/11/21 | Valid | 21/11/2030 | Chemical | 2025/11/21 | New application|CEP granted|21/11/2025 | |
| 2017 | Oxaliplatin | SHANDONG BOYUAN PHARMACEUTICAL CO., LTD. Jinan City CN | 100037406;100076812 | CEP 2013-113 - Rev 01 | 2025/11/21 | Valid | Chemical | 2026/01/19 | Minor revision|Accepted - CEP remains valid|19/01/2026; Minor revision|CEP granted|21/11/2025 |
||
| 1794 | Paclitaxel | WUXI TAXUS PHARMACEUTICAL CO. LTD. Wuxi City CN | 100052831;100093126 | CEP 2024-437 - Rev 00 | 2025/11/21 | Valid | 21/11/2030 | Chemical | 2025/11/21 | New application|CEP granted|21/11/2025 | |
| 1702 | Naproxen sodium | HETERO LABS LIMITED Hyderabad IN | 100011681;100018664 | CEP 2022-389 - Rev 01 | 2025/11/19 | Valid | 13/09/2029 | Chemical | 2025/11/19 | Minor revision|CEP granted|19/11/2025; New application|CEP granted|16/09/2024 |
|
| 2756 | Amorolfine hydrochloride, Nantong site | SIEGFRIED AG Zofingen CH | 100011797;100022117 | CEP 2017-251 - Rev 01 | 2025/11/19 | Valid | Chemical | 2025/11/19 | Minor revision|CEP granted|19/11/2025; Minor revision|Accepted - CEP remains valid|22/08/2024; Renewal|CEP granted|11/01/2023 |
||
| 781 | Phenoxyethanol | ICN POLFA RZESZOW S.A. Rzeszow PL | 100000280;100004301 | CEP 2023-276 - Rev 01 | 2025/11/19 | Valid | 06/05/2029 | Chemical | 2025/11/19 | Minor revision|CEP granted|19/11/2025; New application|CEP granted|06/05/2024 |
|
| 67 | Folic acid hydrate | ZHEJIANG SHENGDA BIO-PHARM CO., LTD. Tiantai CN | 100024864;100041389 | CEP 2023-161 - Rev 01 | 2025/11/19 | Valid | 13/11/2029 | Chemical | 2025/11/19 | Notification|CEP granted|19/11/2025; New application|CEP granted|13/11/2024 |
|
| 2341 | Cefpodoxime proxetil, Process 3 | QILU ANTIBIOTICS PHARMACEUTICAL CO. LTD. Jinan CN | 100033695;100052910 | CEP 2020-399 - Rev 02 | 2025/11/19 | Valid | Chemical | 2025/11/19 | Renewal|CEP granted|19/11/2025; Minor revision|CEP granted|03/01/2025; Notification|Accepted - CEP remains valid|17/11/2022; Minor revision|Accepted - CEP remains valid|18/01/2022; New application|CEP granted|15/03/2021 |
||
| 3087 | Ticagrelor, Standard, micronised | ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. Starogard Gdański PL | 100000470;100001572 | CEP 2020-338 - Rev 04 | 2025/11/19 | Valid | 15/05/2028 | Chemical | 2025/11/19 | Notification|CEP granted|19/11/2025; Minor revision|CEP granted|27/10/2025; Minor revision|CEP granted|23/08/2024; Minor revision|CEP granted|17/01/2024; New application|CEP granted|15/05/2023 |
请输入需要查询的英文物质名称,证书持有人,证书编号,专论编号